Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2018 Mar 28;17(6):1196–1206. doi: 10.1158/1535-7163.MCT-17-0682

Figure 2. In vivo tumoritropic properties of nano–engineered MSCs.

Figure 2

MSCs engineered with near-infrared dye SDB 5491 labeled nanoparticles were injected in both (A) tumor-free and (B) A549–luc orthotopic lung tumor-bearing mice. Fluorescence images were captured at different time points. (C) MSCs engineered with SDB 5491 labeled nanoparticles were injected in A549–luc orthotopic lung tumor bearing mice and both the fluorescence and bioluminescence images were captured at 24 h post injection.